Decreased striatal levels of PEP-19 following MPTP lesion in the mouse. - Wikidata - wikimedia - TriplyDB

Decreased striatal levels of PEP-19 following MPTP lesion in the mouse.

Decreased striatal levels of PEP-19 following MPTP lesion in the mouse.

http://www.wikidata.org/entity/Q33233050

about

Impaired locomotor learning and altered cerebellar synaptic plasticity in pep-19/PCP4-null mice Imaging mass spectrometry in neuroscience.Future technology insight: mass spectrometry imaging as a tool in drug research and development.Top-down proteomics with mass spectrometry imaging: a pilot study towards discovery of biomarkers for neurodevelopmental disorders Mass spectrometry imaging, an emerging technology in neuropsychopharmacology.Quality measures of imaging mass spectrometry aids in revealing long-term striatal protein changes induced by neonatal exposure to the cyanobacterial toxin β-N-methylamino-L-alanine (BMAA)Probing neuropeptide signaling at the organ and cellular domains via imaging mass spectrometry.Neonatal exposure to the cyanobacterial toxin BMAA induces changes in protein expression and neurodegeneration in adult hippocampus Recent advances in single-cell MALDI mass spectrometry imaging and potential clinical impact Matrix-assisted laser desorption/ionization imaging mass spectrometry.Mass spectrometric imaging for biomedical tissue analysis MALDI imaging mass spectrometry: state of the art technology in clinical proteomics.In situ molecular imaging of proteins in tissues using mass spectrometry.MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology.The calmodulin regulator protein, PEP-19, sensitizes ATP-induced Ca2+ release SwePep, a database designed for endogenous peptides and mass spectrometry.Imaging of peptides in the rat brain using MALDI-FTICR mass spectrometry.Tissue imaging using MALDI-MS: a new frontier of histopathology proteomics.Mitochondrial dysfunction in mouse models of Parkinson's disease revealed by transcriptomics and proteomics Approaching MALDI molecular imaging for clinical proteomic research: current state and fields of application.Neuroproteomics as a promising tool in Parkinson's disease research.MALDI mass spectrometry based molecular phenotyping of CNS glial cells for prediction in mammalian brain tissue.Application of matrix-assisted laser desorption/ionization mass spectrometric imaging to monitor surface changes of UV-irradiated poly(styrene) films.Desorption electrospray ionization then MALDI mass spectrometry imaging of lipid and protein distributions in single tissue sections Challenges and recent advances in mass spectrometric imaging of neurotransmitters.Automated anatomical interpretation of ion distributions in tissue: linking imaging mass spectrometry to curated atlases.Mapping of neuropeptides in the crustacean stomatogastric nervous system by imaging mass spectrometry.MALDI mass spectrometric imaging meets "omics": recent advances in the fruitful marriage.Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analyses of the striata in two mouse models of Parkinson's disease.The use of MALDI-MSI in the investigation of psychiatric and neurodegenerative disorders: A review.Imaging mass spectrometry: principle and application.Imaging mass spectrometry of neuropeptides in decapod crustacean neuronal tissues.Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseases Proteomics in animal models of Alzheimer's and Parkinson's diseases.Striatal alterations of secretogranin-1, somatostatin, prodynorphin, and cholecystokinin peptides in an experimental mouse model of Parkinson disease.Proteomics in Parkinson's disease: current trends, translational snags and future possibilities.Anatomo-proteomic characterization of human basal ganglia: focus on striatum and globus pallidus.Mass spectrometry imaging for clinical research - latest developments, applications, and current limitations.Proteomic studies associated with Parkinson's disease.Imaging mass spectrometry in drug development and toxicology

P2860

Q24634111-241C940C-D9A6-4C0D-B933-9F776AEDC59F Q27024594-42A47423-50C9-4266-8130-6EE8C895EDF4 Q28087460-28E07FAD-F709-42B6-843D-B8BB2D3EBA49 Q28542079-E9F512B2-2D33-44F3-9470-EA69B77A99BF Q30422058-F0380756-1217-44A3-B909-34270AD95A81 Q30444494-5EE87DAB-FF87-4CA0-8EE1-CD7156E54329 Q30450144-4A58AAFA-022E-4C5E-B32C-CCACAE8E5578 Q30460930-7168EB7C-C430-4293-816B-065A00A88168 Q30465139-DE4CF1FB-7389-45CC-8692-6F7A070F1358 Q30475419-3D90B8F7-7401-4651-BC5B-1F6A40281D1B Q30475508-A359C50A-8373-4A56-A860-EEA3ABCAD04E Q30479784-F340F5B3-C368-493E-93D7-90DB5CF16DC9 Q30479962-F6EFDF4D-26C3-4829-A9A2-FC2378E1C990 Q30493634-9A34FDB6-3653-4CF3-87A1-6A7A778FD48A Q30668614-596CF75B-43B3-4374-9E90-EDE0DADB48FA Q33234755-F49CB1BB-4BBC-450F-B688-08734476691B Q33261082-75631047-EF22-4036-A49D-55400880BD1F Q33340661-67EFB768-8CBD-42E9-B6EA-286E2DCAEB3B Q33605431-B13AD818-8275-4D96-91B8-A2A1D9C5B56F Q33766329-94C88389-30AA-48A9-8950-2C8332F4B8D3 Q33821316-FF51CA9B-1F63-43B0-922F-EEC243540A9D Q33892813-81E85E6D-E55B-45D7-B3DE-CB999D5D37A7 Q34018148-E3948D8B-43E2-4E08-9883-3758D60D11BB Q34040984-7FB703F9-6867-4968-8821-41D7B532E031 Q34157765-55D4C951-F67C-48B8-A547-97B1C02EF71A Q34193914-8F21F3AB-ABEB-461B-B50B-A6B68E3BE9EC Q34495004-0F5AB8D2-1BFA-4AAC-8DEF-8BB36E45601E Q35687880-F1A76C9B-BF73-42BE-B36E-5FD311C34BF3 Q35869111-0A033987-C00A-4CB2-B861-A57359B0B503 Q36052708-6CC7240B-1C97-4051-A10A-EABE123A5C32 Q36373018-C9FF2166-B68D-4FC2-8B5B-27343A9889E0 Q36862646-5399C984-37B8-4132-B66F-7E313B8F4E17 Q36974613-7421A8CD-E78E-4322-9B3C-D1846F8CBEB0 Q37071539-D2CFFDC6-9536-46C3-A6BD-E60D836F96C7 Q37210678-7501AE4B-A983-4D48-AE4F-BFA08612EDB5 Q37685124-C9849A12-05B0-49A8-955D-295639352F27 Q38470416-FDF7016F-9C92-4043-8566-E1BC4AFB5D85 Q38712870-1DCCE89B-CDCD-4538-B67D-99697219FB80 Q38761409-4D08ED0D-967A-4886-9631-1A7A19AA83A4 Q39033781-6E3AB08C-D89A-44B6-B890-9B3D02F92C6D

P2860

Decreased striatal levels of PEP-19 following MPTP lesion in the mouse.

http://www.wikidata.org/entity/Q33233050

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Decreased striatal levels of PEP-19 following MPTP lesion in the mouse.

@ast

Decreased striatal levels of PEP-19 following MPTP lesion in the mouse.

@en

type

label

Decreased striatal levels of PEP-19 following MPTP lesion in the mouse.

@ast

Decreased striatal levels of PEP-19 following MPTP lesion in the mouse.

@en

prefLabel

Decreased striatal levels of PEP-19 following MPTP lesion in the mouse.

@ast

Decreased striatal levels of PEP-19 following MPTP lesion in the mouse.

@en

P1433

Q33233050-5B12B31D-F303-4FCF-8C00-8153327B0B3F

P1476

Q33233050-44C9A6A8-5AF6-4C84-BDE7-5A8C66D5E220

P2093

Q33233050-54A316C4-46F2-4443-8B3A-0526E3A914AD

Q33233050-77CDE420-EE06-4BB4-BCBD-DF2984CEBFC2

Q33233050-9A226A74-3428-48E3-BCE8-EF8B053328CF

Q33233050-9B67AC9A-0568-4C1F-81A6-832742C20BD3

Q33233050-A5662C17-538C-499F-9819-DC10368C37CD

Q33233050-B35BF9AF-83F7-4F3F-86F2-AEFA2E2E0A55

Q33233050-D10459CC-165E-4164-A433-3E6AF99944CF

P304

Q33233050-CAFBC26A-7CC0-4B47-A9BE-39374242A963

P31

Q33233050-F4BB7A5D-4C8B-47F8-B547-6B67215F72CD

P356

Q33233050-8EA33393-E38A-4552-B4E1-13F7617534CF

P433

Q33233050-379771B1-D574-4295-8DD6-B5F817AB850F

P478

Q33233050-DA8C70AC-8B95-4915-B0C2-6BD7FF30E461

P50

Q33233050-FA6C3C33-087F-4B7E-A88B-D5085273A11D

P577

Q33233050-661EAC97-BCBA-484F-B87C-672BB1D60BD1

P5875

Q33233050-407C1479-1CFF-4567-8629-AB0FD77CF8C4

P698

Q33233050-5AA921F1-E30F-40A5-B4BB-BAA0509DD7DD

P921

Q33233050-ACD280DC-89D6-4924-8FCB-6BBF9701CCB5

P356

P1433

Journal of Proteome Research

P1476

Decreased striatal levels of PEP-19 following MPTP lesion in the mouse.

@en

P2093

Anna Nilsson

http://www.w3.org/2001/XMLSchema#string

Karl Sköld

http://www.w3.org/2001/XMLSchema#string

Katarina Nydahl

http://www.w3.org/2001/XMLSchema#string

Marcus Svensson

http://www.w3.org/2001/XMLSchema#string

Per E Andrén

http://www.w3.org/2001/XMLSchema#string

Richard M Caprioli

http://www.w3.org/2001/XMLSchema#string

Xiaoqun Zhang

http://www.w3.org/2001/XMLSchema#string

P304

262-269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/PR050281F

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Per Svenningsson

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7315846

http://www.w3.org/2001/XMLSchema#string

P698

16457591

http://www.w3.org/2001/XMLSchema#string

P921

corpus striatum